Accelerate New York Seed Fund was a venture capital firm, founded in 2017 and based in Melville, New York, that focused on supporting early-stage science and technology ventures. The firm has completed its investments, supporting over 20 companies in New York.
Key people at Accelerate New York Seed Fund.
Key people at Accelerate New York Seed Fund.
Accelerate New York Seed Fund is an early-stage venture capital firm focused on providing critical seed and pre-seed funding to science and technology-based startups, particularly those emerging from university research and engineering innovation in New York. Its mission centers on supporting early-stage ventures that leverage cutting-edge science and technology to drive growth and commercialization. The fund primarily invests in startups rooted in university-based innovation, aiming to bridge the gap between academic research and market-ready products. By doing so, it plays a vital role in nurturing the startup ecosystem in New York, especially in sectors related to science, engineering, and high technology[1][2].
The Accelerate New York Seed Fund was established to address the funding gap for early-stage science and technology ventures in the New York area. While specific founding year details are not explicitly available, the fund has evolved as part of a broader initiative to stimulate high-tech startup growth in the region, often in partnership with state and regional economic development programs. Key partners include university technology transfer offices and regional innovation networks, which help source promising startups. The fund’s focus has consistently been on university-based science and engineering innovation, reflecting a strategic evolution to capitalize on New York’s strong academic and research institutions[1][2][3][4].
Accelerate New York Seed Fund rides the trend of increasing commercialization of university research and the growing importance of early-stage capital in science and technology sectors. The timing is crucial as New York continues to build its reputation as a hub for tech innovation beyond traditional finance and media industries. Market forces such as increased state support for innovation, a growing number of university spinouts, and a rising demand for seed-stage funding in high-tech sectors work in the fund’s favor. By focusing on university-based ventures, the fund helps translate academic breakthroughs into viable businesses, thereby strengthening the regional innovation ecosystem and contributing to economic growth[1][2][3][4].
Looking ahead, Accelerate New York Seed Fund is well-positioned to capitalize on the expanding pipeline of university-driven startups in science and engineering. Trends such as increased federal and state funding for research, growing interest in deep tech, and the maturation of New York’s innovation infrastructure will likely shape its trajectory. The fund’s influence is expected to grow as it continues to bridge the gap between academia and industry, fostering startups that could become significant players in their fields. Its ongoing partnerships and focus on early-stage capital will remain critical in sustaining the momentum of New York’s tech ecosystem and driving long-term regional economic development[1][2][4].
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2020 | Qunnect | $800K Seed | — | Airbus Ventures, Luminate Accelerator |
| Sep 1, 2018 | TargaGenix Inc. | $100K Seed | — | — |
| Mar 1, 2018 | Concarlo Therapeutics | $7.0M Seed | — | — |
| Dec 1, 2017 | Bioharmony Therapeutics | $100K Seed | — | — |
